Chemical Name: | 5'H-Pregna-1,4-dieno[17,16-d]oxazole-3,20-dione,11,21-dihydroxy-2'-methyl-, (11b,16b)- |
CAS Number: | 13649-57-5 |
Product Number: | AG0011X8(AGN-PC-0PKZ3E) |
Synonyms: | |
MDL No: | |
Molecular Formula: | C23H29NO5 |
Molecular Weight: | 399.4801 |
Deacetyldeflazacort is a chemically modified derivative of deflazacort, a glucocorticoid medication that is used to treat a variety of inflammatory and autoimmune conditions. In chemical synthesis, Deacetyldeflazacort is a valuable intermediate for the production of novel steroid compounds. Its precise structural modifications provide unique opportunities for further derivatization, enabling the synthesis of diverse analogs with varying pharmacological properties.In organic chemistry, Deacetyldeflazacort serves as a key building block for the creation of biologically active molecules through strategic functional group manipulations and scaffold diversifications. Its specific molecular framework offers a means to tailor the physicochemical and pharmacokinetic properties of synthesized compounds, thereby enhancing their therapeutic efficacy and safety profiles. By incorporating Deacetyldeflazacort into synthetic routes, chemists can access a broad spectrum of steroid derivatives with potential applications in drug development and medicinal chemistry research.